ClinicalTrials.Veeva

Menu

Interest of Procore Needle® for Diagnosis of Lung Cancer

P

Poitiers University Hospital

Status

Completed

Conditions

Endobronchial Transbronchial Needle Aspiration Lung Cancer Procore

Treatments

Procedure: Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration

Study type

Interventional

Funder types

Other

Identifiers

NCT02931461
PR-EBUS

Details and patient eligibility

About

The ProCore ultrasound biopsy needle, used primarily to obtain intra-abdominal tissue core biopsies, has not been widely used for endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA). In this study the investigators are going to evaluate the utility of the ProCore needle for sampling mediastinal or hilar lymph nodes during EBUS-TBNA versus standard 22 gauge needle for diagnosis of lung cancer.

Enrollment

49 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • mediastinal lymphadenopathy >10 millimeters
  • lung cancer suspected

Exclusion criteria

  • coagulopathy contraindication for midazolam contraindication for bronchoscopy

Trial design

49 participants in 2 patient groups

needle Procore ®
Experimental group
Treatment:
Procedure: Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration
needle Cook®
Active Comparator group
Treatment:
Procedure: Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems